A man in his late 70s with no psychiatric history developed restlessness, depressive mood, and attempted suicide one month after starting semaglutide, with psychiatric symptoms improving after drug discontinuation.
No psychiatric history + first attemptAn elderly diabetic man with no prior mental health issues attempted suicide one month after starting semaglutide—highlighting the need for mood monitoring
What the researchers found
Late 70s male; no psychiatric history; T2DM. Developed restlessness + depressive mood ~1 month after semaglutide start. First suicide attempt (impulsive). Symptoms improved after semaglutide discontinuation.
Why it matters
While umbrella reviews find no population-level suicidal risk signal, individual case reports like this highlight that some patients may be vulnerable. The absence of psychiatric history makes this case particularly notable.
How the study worked
Single case report with temporal association.
What this study cannot tell us
Single case. Cannot prove causation. Temporal association could be coincidental. Other factors may have contributed. Very rare event.
How to read the evidence
Single case report. Cannot establish causation but important for safety vigilance.
When this study was published
Published in 2025.
The bigger picture
This case, alongside the broader suicidality surveillance data, suggests that while overall GLP-1 drug risk is low, individual monitoring—especially in elderly patients initiating treatment—remains important.
Questions still open
- Are elderly patients more susceptible to GLP-1 psychiatric effects?
- Should mood screening be routine when starting semaglutide?
- What mechanism could cause semaglutide-related mood changes?
Common questions
Can semaglutide cause depression or suicidal thoughts?
Should I worry about mental health effects on semaglutide?
Read the original research
Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report.
The Journal of international medical research, 53(7), 3000605251349393
Citation
Stojkovska, Anisija; Rus Prelog, Polona; Kokalj Palandacic, Anja. (2025). Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report.. The Journal of international medical research, 53(7), 3000605251349393. https://doi.org/10.1177/03000605251349393